BioSpace News Archive

Business

Corsair Pharma and United Therapeutics Enter Into Strategic Collaboration to Advance Novel Treprostinil Prodrugs

Under the terms of the license agreement, United Therapeutics has been granted an exclusive license to Corsair’s intellectual property for the development of treprostinil prodrug formulations.

January 3, 2018
·
6 min read
Press Releases

Maravai Acquires Glen Research

Maravai, a leader in providing specialty reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced the acquisition of Sterling, VA based Glen Research.

January 3, 2018
·
1 min read
Business

Egalet Partners With OraPharma to Co-Promote SPRIX Nasal Spray

SPRIX Nasal Spray is a NSAID indicated for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level.

January 3, 2018
·
12 min read
Business

Merck to Hold Fourth-Quarter and Full-Year 2017 Sales and Earnings Conference Call on February 2

Merck will hold its fourth-quarter and full-year 2017 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Friday, February 2.

January 3, 2018
·
3 min read
PlaqueTec Announces First Peer-Reviewed Publication for its Liquid Biopsy System (LBS)

PlaqueTec today announced the publication of the first peer-reviewed article demonstrating the feasibility and potential of the PlaqueTec Liquid Biopsy System to detect biomarkers for coronary artery disease.

January 3, 2018
·
5 min read
Biotech Beach

PROCEPT BioRobotics Completes Enrollment in WATER II Pivotal Clinical Trial

The WATER II Study is a U.S. investigational device exemption (IDE) clinical trial evaluating the safety and efficacy of Aquablation therapy.

January 3, 2018
·
4 min read
Policy

Palatin Technologies Announces FDA Clearance of IND Application for PL-8177 for Ulcerative Colitis

Palatin expects to commence a Phase 1 single and multiple ascending dose study in the current quarter.

January 3, 2018
·
3 min read
Drug Development

Omeros Corporation Reaches Agreement with FDA on OMS721 Phase 3 Trial Protocol for IgA Nephropathy

Omeros announced that it has reached agreement with the FDA on Omeros’ protocol for its Phase 3 clinical trial evaluating OMS721 in patients with IgA nephropathy (IgAN). Patient enrollment is expected to begin early next month.

January 3, 2018
·
9 min read
Business

Alligator Bioscience to Receive USD 6 Million Milestone Payment From Janssen Coupled to the Decision to Initiate Combination Trial With ADC-1013

This is the first out of a number of pre-defined milestones, related to the start of combination or phase II studies as part of the ADC-1013 clinical program.

January 3, 2018
·
3 min read
Policy

Asana BioSciences Announces Acceptance of IND Application for Its Oral ERK1/2 Inhibitor

Asana BioSciences announced that the U.S. FDA has accepted the IND application for ASN007, a potent and selective ERK1/2 inhibitor.

January 3, 2018
·
3 min read